Asamura H, Naruke T, Tsuchiya R, Goya T, Kondo H, Suemasu K
Department of Surgery, National Cancer Center Hospital, Tokyo, Japan.
J Thorac Cardiovasc Surg. 1992 Nov;104(5):1456-64.
During a 28-year period, 52 bronchopleural fistulas developed after pulmonary resection of 49 primary and three recurrent lung cancers at the National Cancer Center Hospital, Tokyo. During the same period there were 2359 pulmonary resections for primary lung cancer; the prevalence of bronchopleural fistula was 2.1%. Multivariate analysis on 15 variables in the most recent 1360 resections revealed significant risk factors for bronchopleural fistula: wider resection such as pneumonectomy, residual carcinomatous tissue at the bronchial stump, preoperative irradiation, and diabetes. Univariate analysis further recognized a risk in preoperative bronchial arterial infusion and the postsurgical stage of lung cancer. Six patients were not treated. Apart from chest tube drainage in seven patients, surgical repair was attempted in 39, direct resuture of the stump in 16, wrapping in 25, thoracoplasty in 31, completion pneumonectomy in 6, and other treatments. Despite various treatments, 37 patients (71.2% mortality) died from fistula-related complications (such as regurgitation of infected pleural fluid through the fistula and airway/intrathoracic bleeding). Even for patients whose fistulas were cured and who were discharged, the average hospital stay was 189 days. Further investigation is necessary to answer whether prevention by flap coverage is of any benefit.
在28年期间,东京国立癌症中心医院对49例原发性肺癌和3例复发性肺癌进行肺切除术后发生了52例支气管胸膜瘘。同期,因原发性肺癌进行肺切除的有2359例;支气管胸膜瘘的发生率为2.1%。对最近1360例切除术的15个变量进行多因素分析,发现支气管胸膜瘘的显著危险因素有:更广泛的切除,如全肺切除术、支气管残端残留癌组织、术前放疗和糖尿病。单因素分析进一步确认术前支气管动脉灌注和肺癌术后分期存在风险。6例患者未接受治疗。除7例患者行胸腔闭式引流外,39例尝试手术修复,16例行残端直接缝合,25例行包裹术,31例行胸廓成形术,6例行全肺切除术及其他治疗。尽管采取了各种治疗措施,37例患者(死亡率71.2%)死于与瘘相关的并发症(如感染性胸腔积液通过瘘管反流和气道/胸腔内出血)。即使是瘘已治愈并出院的患者,平均住院时间也为189天。对于皮瓣覆盖预防是否有益,还需要进一步研究。